TP53 and cancer: A pan-cancer bioinformatic analysis demonstrated coherent expression between CDK1 and cellular pathways often dysregulated in cancer, including cell-cycle-related targets, the G2/M DNA damage checkpoint, mTORC1 signaling, MYC target genes, and the p53 pathway.291